Boone Capital Management LLC reported 16 holdings worth US$377M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Boone Capital Management LLC reported 16 holdings worth US$377M as of Sep 30, 2026. Largest: BioMarin Pharmaceutical Inc., Teleflex Incorporated and Mirum Pharmaceuticals, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 16
- Value as reported
- US$377M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 672K | US$40.3M | 10.7% |
| Teleflex Incorporated | 289K | US$36.1M | 9.6% |
| Mirum Pharmaceuticals, Inc. | 416K | US$35.5M | 9.4% |
| UnitedHealth Group Incorporated | 88,687 | US$32.6M | 8.6% |
| The Cigna Group | 112K | US$30.5M | 8.1% |
| Guardian Pharmacy Services, Inc. | 725K | US$29.6M | 7.8% |
| Avantor, Inc. | 1.84M | US$27.7M | 7.3% |
| Labcorp Holdings Inc. | 87,551 | US$27M | 7.2% |
| Encompass Health Corporation | 206K | US$25M | 6.6% |
| Vestis Corporation | 1.58M | US$21.2M | 5.6% |
| The Pennant Group, Inc. | 526K | US$20.5M | 5.4% |
| BridgeBio Pharma, Inc. | 277K | US$18.3M | 4.8% |
| Waystar Holding Corp. | 509K | US$12.9M | 3.4% |
| Cullinan Therapeutics, Inc. | 691K | US$10.6M | 2.8% |
| Maze Therapeutics, Inc. | 179K | US$4.88M | 1.3% |
| Adlai Nortye Group Ltd. | 258K | US$4.13M | 1.1% |
| Ionis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Kodiak Sciences Inc | 0 | US$0 | 0.00% |
| Kymera Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Monte Rosa Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tango Therapeutics, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC